SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids on dialysis: trial tests drug to control dangerous hormone imbalance
Disease control Recruiting nowThis study is testing a drug called etelcalcetide in children and infants with advanced kidney disease who are on dialysis. The drug aims to control a common and serious hormone problem that causes bone disease and growth problems. Researchers want to see if it is safe and effect…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for kids on dialysis: trial tests drug to control dangerous hormone levels
Disease control Recruiting nowThis study is testing a drug called etelcalcetide in children and teens with advanced kidney disease who are on dialysis. The goal is to see if it safely and effectively lowers high levels of a harmful hormone that can damage bones and the heart. Researchers will monitor 24 parti…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC